82 related articles for article (PubMed ID: 18843032)
1. The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings.
Cárdenas-Turanzas M; Nogueras-Gonzalez GM; Scheurer ME; Adler-Storthz K; Benedet JL; Beck JR; Follen M; Cantor SB
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2865-71. PubMed ID: 18843032
[TBL] [Abstract][Full Text] [Related]
2. The accuracy of the Papanicolaou smear in the screening and diagnostic settings.
Cárdenas-Turanzas M; Follen M; Nogueras-Gonzalez GM; Benedet JL; Beck JR; Cantor SB
J Low Genit Tract Dis; 2008 Oct; 12(4):269-75. PubMed ID: 18820540
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings.
Kuhn L; Denny L; Pollack A; Lorincz A; Richart RM; Wright TC
J Natl Cancer Inst; 2000 May; 92(10):818-25. PubMed ID: 10814677
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
[TBL] [Abstract][Full Text] [Related]
5. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus detection in cervical lesions nondiagnostic for cervical intraepithelial neoplasia: correlation with Papanicolaou smear, colposcopy, and occurrence of cervical intraepithelial neoplasia.
Nuovo GJ; Blanco JS; Leipzig S; Smith D
Obstet Gynecol; 1990 Jun; 75(6):1006-11. PubMed ID: 2160630
[TBL] [Abstract][Full Text] [Related]
7. [Pap smear, hybrid capture II, and visual inspection in screening for uterine cervical lesions].
Gontijo RC; Derchain SF; Montemor EB; Sarian LO; Serra MM; Zeferino LC; Syrjanen KJ
Cad Saude Publica; 2005; 21(1):141-9. PubMed ID: 15692647
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening program integrating Pap smear and HPV DNA testing: a population-based study.
Chao A; Hsu KH; Lai CH; Huang HJ; Hsueh S; Lin SR; Jung SM; Chao FY; Huang SL; Huang CC; Yang JE; Chang TC
Int J Cancer; 2008 Jun; 122(12):2835-41. PubMed ID: 18338752
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of polymerase chain reaction (PCR) method and hybrid capture II (HCII) assay for the detection of human papillomavirus in cervical scrapings.
Saini R; Shen TH; Othman NH; Santhanam J; Othman N; Tang TH
Med J Malaysia; 2007 Aug; 62(3):206-9. PubMed ID: 18246908
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of several cervical screening strategies for early detection of cervical cancer: a meta-analysis.
Chen C; Yang Z; Li Z; Li L
Int J Gynecol Cancer; 2012 Jul; 22(6):908-21. PubMed ID: 22672987
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence spectroscopy for diagnosis of squamous intraepithelial lesions of the cervix.
Mitchell MF; Cantor SB; Ramanujam N; Tortolero-Luna G; Richards-Kortum R
Obstet Gynecol; 1999 Mar; 93(3):462-70. PubMed ID: 10075001
[TBL] [Abstract][Full Text] [Related]
12. Screening for squamous intraepithelial lesions with fluorescence spectroscopy.
Mitchell MF; Cantor SB; Brookner C; Utzinger U; Schottenfeld D; Richards-Kortum R
Obstet Gynecol; 1999 Nov; 94(5 Pt 2):889-96. PubMed ID: 10546779
[TBL] [Abstract][Full Text] [Related]
13. Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to papanicolaou smear in the triage of women with cervical cytologic abnormalities.
Franco EL; Ferenczy A
Am J Obstet Gynecol; 1999 Aug; 181(2):382-6. PubMed ID: 10454687
[TBL] [Abstract][Full Text] [Related]
14. A methodological framework to distinguish spectrum effects from spectrum biases and to assess diagnostic and screening test accuracy for patient populations: application to the Papanicolaou cervical cancer smear test.
Elie C; Coste J;
BMC Med Res Methodol; 2008 Feb; 8():7. PubMed ID: 18291032
[TBL] [Abstract][Full Text] [Related]
15. Does providing previous results change the accuracy of cervical cytology?
Davey E; Irwig L; Macaskill P; Clarke J; Thurloe J; Hyne S; Biro C
Acta Cytol; 2009; 53(6):644-52. PubMed ID: 20014553
[TBL] [Abstract][Full Text] [Related]
16. Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings.
Luu HN; Adler-Storthz K; Dillon LM; Follen M; Scheurer ME
Clin Med Insights Oncol; 2013; 7():247-55. PubMed ID: 24137052
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of diagnostic tests with imperfect reference standards.
Walter SD; Irwig L; Glasziou PP
J Clin Epidemiol; 1999 Oct; 52(10):943-51. PubMed ID: 10513757
[TBL] [Abstract][Full Text] [Related]
18. Emerging technologies and cervical cancer.
Follen M; Richards-Kortum R
J Natl Cancer Inst; 2000 Mar; 92(5):363-5. PubMed ID: 10699061
[No Abstract] [Full Text] [Related]
19. Selective screening for cervical neoplasia: an approach for resource-poor settings.
Hoyo C; Miller WC; Newman BM; Fortney JA
Int J Epidemiol; 2000 Oct; 29(5):807-12. PubMed ID: 11034961
[TBL] [Abstract][Full Text] [Related]
20. Performance estimation of diagnostic tests for cervical precancer based on fluorescence spectroscopy: effects of tissue type, sample size, population, and signal-to-noise ratio.
Utzinger U; Trujillo EV; Atkinson EN; Mitchell MF; Cantor SB; Richards-Kortum R
IEEE Trans Biomed Eng; 1999 Nov; 46(11):1293-303. PubMed ID: 10582414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
